Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children

Pediatric Infectious Disease Journal

Volumn 26, Issue 9, 2007, Pages 846-849

  Micheloud, Dariela ^a   Jensen, Julia ^a   Bellón, José M ^a   Gurbindo, Dolores ^a   De José, Ma Isabel ^b   Moreno, David ^c   Ramos, José T ^d   Muñoz Fernández, Ma Angeles ^a   Resino, S ^a   Ramos, J T ^d   Gonzalez Tome M I ^d   Guillen, S ^d   Ruiz Contreras, J ^d   Micheloud, M D ^a   Bellon J M ^a   Jensen, J ^a   Gurbindo, D ^a   Navarro, M L ^a   Resino, R ^a   Munoz Fernandez M A ^a   Isabel De Jose M I ^b   Larru, B ^b   Martin Fontelos P ^b   Mellado, M J ^b   Moreno, D ^c   Gonzalez, R ^e   more..

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e Sant Joan d'Alacant   (Spain)

Author keywords

AIDS; CD4+; CD8+; Hepatic enzymes; Hepatitis C; Liver fibrosis; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MALE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 34548279491     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e318123e8e6     Document Type: Article

References (19)

1. Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis. 2001;183: 1112-1115.
2. Martinez-Sierra C, Arizcorreta A, Diaz F, et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis. 2003;36:491-498.
3. Greub G, Ledergerber B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356:1800-1805.
4. England K, Thorne C, Newell ML. Vertically acquired paediatric coinfection with HIV and hepatitis C virus. Lancet Infect Dis. 2006;6:83-90.
5. Nigro G, D'Orio F, Catania S, et al. Mother to infant transmission of coinfection by human immunodeficiency virus and hepatitis C virus: prevalence and clinical manifestations. Arch Virol. 1997;142:453-457.
6. Papaevangelou V, Pollack H, Rochford G, et al. Increased transmission of vertical hepatitis C virus (HCV) infection to human immunodeficiency virus (HIV)-infected infants of HIV- and HCV-coinfected women. J Infect Dis. 1998;178:1047-1052.
7. CDC. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 1994;43:1-20.
8. CDCP. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR CDC Surveill Summ. 1994;43:1-10.
9. CDCP. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1-19.
10. CDCP. Guidelines for use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep. 1998;47:1-43.
11. Giaquinto C; Paediatric European Network for the Treatment of AIDS Steering Committee. Sharland M, Gibb D, Current evidence for the use of paediatric antiretroviral therapy - a PENTA analysis. Eur J Pediatr. 2000;159:649-656.
12. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Recomm Rep. 1992;41:1-11.
13. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA. 2002;288:199-206.
14. Rockstroh JK, Mocroft A, Soriano V, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis. 2005;192:992-1002.
15. Carlos Martin J, Castilla J, Lopez M, Arranz R, Gonzalez-Lahoz J, Soriano V. Impact of chronic hepatitis C on HIV-1 disease progression. HIV Clin Trials. 2004;5:125-131.
16. Resino S, Resino R, Maria Bellon J, et al. Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children. Clin Infect Dis. 2006;43:243-252.
17. Schuval S, Van Dyke RB, Lindsey JC, et al. Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol. Arch Pediatr Adolesc Med. 2004;158:1007-1013.
18. Al-Harthi L, Voris J, Du W, et al. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells. J Infect Dis. 2006;193:1202-1210.
19. Zuccotti GV, Salvini F, Farina F, Agostoni C, Riva E, Giovannini M. Longitudinal long-term follow-up study of children with vertically acquired hepatitis C virus infection. J Int Med Res. 2006;34:215-222.